Get the Stockscreener App
9.91
4.54%
0.43
After Hours:
9.91
Optimizerx Corp stock is traded at $9.91, with a volume of 237.44K.
It is up +4.54% in the last 24 hours and up +33.20% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$9.48
Open:
$9.63
24h Volume:
237.44K
Relative Volume:
0.48
Market Cap:
$178.28M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-12.39
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
+2.80%
1M Performance:
+33.20%
6M Performance:
+57.80%
1Y Performance:
-6.51%
1-Day Range:
$9.63
$10.40
1-Week Range:
$9.115
$10.40
52-Week Range:
$3.78
$14.13
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
9.91 | 178.28M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
239.53 | 37.82B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.35 | 10.90B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
65.22 | 8.97B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
91.33 | 7.61B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.49 | 6.83B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
OptimizeRx Co. (NASDAQ:OPRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
JPMorgan Chase & Co. Increases Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) to Release Quarterly Earnings on Monday - MarketBeat
Marshall Wace LLP Buys New Shares in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
XTX Topco Ltd Acquires New Shares in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Connors Investor Services Inc. Has $287,000 Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report - The Manila Times
Healthcare Tech Leader OptimizeRx Jumps to Elite 1st Decile in ESG Rating: Key 2025 Report Findings - Stock Titan
Geode Capital Management LLC Has $1.95 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Walleye Capital LLC Acquires Shares of 138,575 OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
OptimizeRx Corp. to Host Conference Call on Q1 2025 Financial Results on May 12, 2025 - Nasdaq
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET - The Manila Times
Kennedy Capital Management LLC Increases Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Analysts Set OptimizeRx Co. (NASDAQ:OPRX) Target Price at $9.06 - MarketBeat
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times
Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Short Interest Up 22.0% in March - MarketBeat
Is OptimizeRx Corporation (NASDAQ:OPRX) Expensive For A Reason? A Look At Its Intrinsic Value - simplywall.st
Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com
OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener
OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat
Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx Corp SEC 10-K Report - TradingView
OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com Australia
OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Q1 Earnings Forecast for OptimizeRx Issued By B. Riley - MarketBeat
Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World
Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN
Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat
Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World
OptimizeRx (NASDAQ:OPRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
2.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):